NOBOX is a key FOXL2 partner involved in ovarian folliculogenesis

Japanese Journal of Clinical Oncology

Volumn 6, Issue 2, 2014, Pages 175-177

  Bouilly, Justine ^a,b   Veitia, Reiner A ^c,d   Binart, Nadine ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c INSTITUT JACQUES MONOD   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXL2; TRANSCRIPTION FACTOR NOBOX; UNCLASSIFIED DRUG;

BINDING SITE; CHROMATIN IMMUNOPRECIPITATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LETTER; OVARY FOLLICLE DEVELOPMENT; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION INITIATION;

EID: 84901283524     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: None     Document Type: Letter

References (10)

1. Benayoun, B.A., Caburet, S., Dipietromaria, A., et al. (2008). The identification and characterization of a FOXL2 response element provides insights into the pathogenesis of mutant alleles. Hum. Mol. Genet. 17, 3118-3127.
2. Beysen, D., De, P.A., and De, B.E. (2009). FOXL2 mutations and genomic rearrangements in BPES. Hum. Mutat. 30, 158-169.
3. Bouilly, J.,Bachelot, A.,Broutin, I., et al. (2011).Novel NOBOX loss-of-function mutations account for 6.2% of cases in a large primary ovarian insufficiency cohort. Hum. Mutat. 32, 1108-1113.
4. Choi, Y., and Rajkovic, A. (2006). Characterization of NOBOX DNA binding specificity and its regulation of Gdf9 and Pou5f1 promoters. J. Biol. Chem. 281, 35747-35756.
5. Foucher, I., Montesinos, M.L., Volovitch, M., et al. (2003). Joint regulation of the MAP1B promoter by HNF3beta/Foxa2 and Engrailed is the result of a highly conserved mechanism for direct interaction of homeoproteins and Fox transcription factors. Development 130, 1867-1876.
6. Moumne, L., Batista, F., Benayoun, B.A., et al. (2008). The mutations and potential targets of the forkhead transcription factor FOXL2. Mol. Cell. Endocrinol. 282, 2-11.
7. Qin, Y., Choi, Y., Zhao, H., et al. (2007). NOBOX homeobox mutation causes premature ovarian failure. Am. J. Hum. Genet. 81, 576-581.
8. Rajkovic, A., Pangas, S.A., Ballow, D., et al. (2004). NOBOX deficiency disrupts early folliculogenesis and oocyte-specific gene expression. Science 305, 1157-1159.
9. Schmidt, D., Ovitt, C.E., Anlag, K., et al. (2004). The murine winged-helix transcription factor Foxl2 is required for granulosa cell differentiation and ovary maintenance. Development 131, 933-942.
10. Uda, M., Ottolenghi, C., Crisponi, L., et al. (2004). Foxl2 disruption causes mouse ovarian failure by pervasive blockage of follicle development. Hum. Mol. Genet. 13, 1171-1181.